^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CARCIK-CD19

    i
    Associations
    News

    Trials

    Company:
    CoImmune
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News

    Trials

    Apply
    Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia (NCT05869279)
    Phase 1/2
    Fondazione Matilde Tettamanti Menotti De Marchi...
    Recruiting
    Last update posted :
    05/03/2024
    Initiation :
    12/01/2023
    Primary completion :
    09/01/2026
    Completion :
    09/01/2027
    BCL2
    |
    MYC rearrangement • BCL2 rearrangement
    |
    CARCIK-CD19
    Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL (NCT05252403)
    Phase 2
    Fondazione Matilde Tettamanti Menotti De Marchi...
    Recruiting
    Last update posted :
    05/04/2023
    Initiation :
    12/01/2021
    Primary completion :
    12/01/2024
    Completion :
    03/01/2025
    CD19
    |
    CD19 positive • CD19 expression
    |
    CARCIK-CD19
    Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT (NCT03389035)
    Phase 1/2
    Fondazione Matilde Tettamanti Menotti De Marchi...
    Completed
    Last update posted :
    05/04/2023
    Initiation :
    12/20/2017
    Primary completion :
    03/31/2021
    Completion :
    12/30/2022
    CD19
    |
    CD19 expression
    |
    CARCIK-CD19